Covid19-Sources
Jan Hartmann on Twitter
Eric Feigl-Ding on Twitter
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Operation Nasal Vaccine—Lightning speed to counter COVID-19
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Fig. 5: Preterm birth and perinatal mortality after SARS-CoV-2 in pregnancy.a,b, Preterm birth (<37 weeks gestation) rate per 100 live births (a) and extended perinatal mortality rates (b) (stillbirths (death in utero ≥24 weeks gestation) and neonatal deaths within 28 d of birth per 1,000 total births) in different cohorts during the pandemic. Background rate is the rate for all babies born during the pandemic period (1 March 2020 to 31 October 2021); no confirmed SARS-CoV-2 is the rate for babies born during the pandemic period (1 March 2020 to 31 October 2021) to women with no confirmed SARS-CoV-2 infection during pregnancy; any SARS-CoV-2 is the rate for babies born to women who had confirmed SARS-CoV-2 during their pregnancy 1 December 2020 to 31 October 2021; SARS-CoV-2 within 28 d of birth is the rate for babies born to women who had confirmed SARS-CoV-2 during their pregnancy 1 December 2020 to 31 October 2021, restricted to babies born within 28 d of the date of onset of maternal infection; Any COVID-19 vaccination is the rate for babies born to women who had COVID-19 vaccination during their pregnancy 1 December 2020 to 31 October 2021; COVID-19 vaccination within 28 d of birth is the rate for babies born to women who had COVID-19 vaccination during their pregnancy 1 December 2020 to 31 October 2021, restricted to babies born within 28 d of the date of maternal vaccination.
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Scholar SARS p53
COVID-19 tied to higher risk of stillbirth, maternal death
Ralf Wittenbrink on Twitter
Martin Moder on Twitter
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
DRKS - Deutsches Register Klinischer Studien (German Clinical Trials Register)
How COVID-19 Can Lead to Diabetes
COVID-19 vaccine tracker and landscape
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro - PubMed
In Cleveland and beyond researchers begin to unravel the mystery of long COVID-19
Unlike flu, COVID-19 attacks DNA in the heart: new research
SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients - 2020.08.25.265561v1.full.pdf
Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot
COVID-19 and children
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
Bert Weingarten on Twitter
Incidence, risk and severity of SARS-CoV-2 reinfections in children and adolescents: a population-level study between March 2020 and July 2022
Long-COVID bei Kindern
Ralf Wittenbrink on Twitter
Life expectancy changes since COVID-19